Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06029907 · ClinicalTrials.gov registry record · Phase 4
Project HOPES: Healthy Options for Pain and Ending Smoking. A Program for Cancer Survivors.
A Phase 4 study, sponsored by Duke University.
- Completed
- Registry status
- Phase 4
- Development phase
- 19
- Enrollment target
NCT06029907: Completed Phase 4 study, sponsored by Duke University.
NCT06029907 is a Phase 4 study that has completed, run by Duke University. The registered enrollment target is 19 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06029907, a Phase 4 study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 19 participants
- Enrollment target
Study Summary
The proposed pilot study will develop and test feasibility, acceptability, and signal for efficacy of a smoking cessation and pain management intervention for 20 cancer survivors.
Primary Outcome
Completing study participation is the number of those who attend all sessions and complete follow-up surveys. This will serve as the feasibility benchmark.
Interventions
- DRUG Varenicline
- OTHER Smoking cessation and pain management intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2024-07-15 |
| Est. Completion | 2025-08-29 |
| Phase | Phase 4 |
What the finished NCT06029907 record still lists
NCT06029907 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 19 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 2 interventions - of which Varenicline is the first listed.
NCT06029907 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06029907 about?
NCT06029907 is a clinical study titled "Project HOPES: Healthy Options for Pain and Ending Smoking. A Program for Cancer Survivors.". The proposed pilot study will develop and test feasibility, acceptability, and signal for efficacy of a smoking cessation and pain management intervention for 20 cancer survivors.
What is the current status of trial NCT06029907?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 19 participants. The study started on 2024-07-15. Estimated completion is 2025-08-29.
What interventions are being tested in trial NCT06029907?
The interventions under investigation include: Varenicline (DRUG), Smoking cessation and pain management intervention (OTHER).
Who is sponsoring clinical trial NCT06029907?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06029907's enrollment target sits among peer trials
19 1834th of 2000 higher than 159 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03207464 · 19 participants · Phase 1
Molecular Imaging of NET Using [C-11]MRB-PET in MS
- NCT04318717 · 19 participants · Phase 2
Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma
- NCT05103904 · 19 participants · Phase 2
Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant
- NCT05607407 · 19 participants · Phase 2
Methimazole in Patients With Progressive Glioblastoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI